India’s HCG acquires Mahatma Gandhi Cancer Hospital for $50m | Healthcare Asia Magazine
, India
140 views
Photo from Envato

India’s HCG acquires Mahatma Gandhi Cancer Hospital for $50m

This enables the company to own a 51% stake in the hospital.

India’s HealthCare Global Enterprises Limited (HCG) is acquring Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI) for approximately $50m (INR414b).

HCG will have an initial 51% stake in the hospital, with plans to complete the acquisition of the additional 34% over the next 18 months.

MGCHRI houses 196 operational beds and features medical technologies including two linear accelerator (LINAC) machines, one PET CT scanner, a robotics surgery system, and a dedicated bone marrow transplant (BMT) unit.

Its clinical team comprises 31 doctors, including surgical, radiation, and medical oncologists.

“This partnership enhances our ability to provide cutting-edge care in Vizag's competitive healthcare landscape,” HCG CEO Raj Gore said.

“We are excited about the opportunities ahead and remain focused on advancing healthcare outcomes for our patients whilst creating sustained value for our stakeholders,” Gore said.

INR 1 = $0.012

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!